1 ALS-02, ALS-05 and ALS-08 (The Avicena
Group): Designated Orphan Drug in Advanced Clinical Testing 6.
The company believes that this patent will provide additional IP protection for its current and future generation drug candidates formulated to treat ALS which extends beyond the existing use patents previously issued to Avicena
with claims in neurology (United States Patents 6,196,115 B1 and 6,706,764 B2).
SciTech21-18 October 2006-BIOTECH COMPANIES IN THE NEWS: The Avicena
is supporting three clinical studies on the effects of creatine among ALS patients.
The key companies studied in this report are Biogen Idec, Avanir Pharmaceuticals, Neuraltus Pharmaceuticals, Cytokinetics, The Avicena
Group, NeuroSearch, Trophos, Amarin Corporation, Siena Biotech, Sanofi.
Key market players covered are Mitsubishi Tanabe Pharma Corporation, Avanir Pharmaceuticals, Avicena
Group and Eisai Pharmaceuticals.
Among the companies participating in the PD market, Merck Serono, Acadia, Axxonis, Avicena
and Solvay were found to be the key players.
Gertler has also been, since May, 2003, a director of Avicena
Group, a biotechnology company listed in the US; and a director, since June, 2007, of Zi Corporation, a technology company providing software products for communication devises and listed on the TSX.
March 12 /PRNewswire-FirstCall/ -- Avicena